Literature DB >> 15047662

Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting.

Jeremy Gilbert1, Janet Raboud, Bernard Zinman.   

Abstract

OBJECTIVE: Coronary artery disease is a significant source of morbidity and mortality in patients with diabetes. Angioplasty has been associated with higher rates of restenosis in patients with diabetes. Numerous studies have been performed to determine whether coronary artery stenting would be useful in decreasing rates of restenosis of coronary vessels in patients with diabetes. This meta-analysis was conducted to determine the effect of diabetes on angiographic restenosis in patients undergoing coronary stenting. RESEARCH DESIGN AND METHODS: Six studies were included comprising 6,236 individuals-1,166 with diabetes and 5,070 without. The relationships between restenosis rates and age, the percentage of the study population that was male, and the percentage of the study population receiving insulin therapy were examined.
RESULTS: The average restenosis rates among patients with and without diabetes were 36.7 and 25.9%, respectively. Restenosis rates were higher among older populations and populations in which a greater percentage of patients with diabetes were treated with insulin, but they did not vary according to the percentage of men in the studies. The odds ratio of coronary artery restenosis associated with diabetes was 1.61 (95% CI 1.21-2.14, P = 0.004) in univariate logistic regression models, but decreased to 1.30 (0.99-1.70, P = 0.055) after controlling for age in multivariate models, suggesting that the higher restenosis rates found in patients with diabetes can in good part be explained by the older ages of patients with diabetes in these studies.
CONCLUSIONS: Although diabetes is a risk factor for restenosis after coronary angioplasty stenting, the apparent effect of diabetes on restenosis rates in the published literature is overstated and was reduced in this meta-analysis by approximately half after adjusting for differences in age.

Entities:  

Mesh:

Year:  2004        PMID: 15047662     DOI: 10.2337/diacare.27.4.990

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

1.  Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.

Authors:  Hongfeng Wang; Dorothee Weihrauch; Judy R Kersten; Jeffrey M Toth; Anthony G Passerini; Anita Rajamani; Sonja Schrepfer; John F LaDisa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

Review 2.  Percutaneous coronary interventions with drug eluting stents for diabetic patients.

Authors:  Ricardo Seabra-Gomes
Journal:  Heart       Date:  2006-03       Impact factor: 5.994

3.  A comparative study of restenosis rates in bare metal and drug-eluting stents.

Authors:  Shilpi Mohan; Anil Dhall
Journal:  Int J Angiol       Date:  2010

Review 4.  Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.

Authors:  C Stettler; S Allemann; M Egger; S Windecker; B Meier; P Diem
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

Review 5.  Restenosis after PCI. Part 1: pathophysiology and risk factors.

Authors:  J Wouter Jukema; Jeffrey J W Verschuren; Tarek A N Ahmed; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-09-13       Impact factor: 32.419

6.  Role of S-1-P receptors and human vascular smooth muscle cell migration in diabetes and metabolic syndrome.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-03-11       Impact factor: 2.192

Review 7.  Revascularization in patients with diabetes: PCI or CABG or none at all.

Authors:  Kreton Mavromatis; Habib Samady; Spencer B King
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

Review 8.  Is the evidence from clinical trials for cardiovascular risk or harm for glitazones convincing?

Authors:  Edoardo Mannucci; Matteo Monami
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

9.  Effect of metabolic syndrome on the response to arterial injury.

Authors:  Yuyang Fu; Enrico A Duru; Mark G Davies
Journal:  J Surg Res       Date:  2014-05-27       Impact factor: 2.192

10.  Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation.

Authors:  Yanqiang Wu; Xianghua Fu
Journal:  J Clin Lab Anal       Date:  2018-09-17       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.